Titan Medical and Teleflex Incorporated Announce Collaboration for Development of Robotic Ligation Technology
25 Março 2019 - 08:00AM
Business Wire
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the
“Company”), a medical device company focused on the design and
development of a robotic surgical system for application in
minimally invasive surgery (“MIS”) and Teleflex Incorporated
(NYSE: TFX), a leading global provider of medical technologies
for critical care and surgery, announce a collaboration under which
Teleflex’s market-leading polymer ligation technology will be
integrated into Titan’s development-stage, single-port robotic
surgery system. Teleflex’s Weck® Hem-o-lok® polymer ligation system
is a proven ligation technology for vessel sealing with enhanced
clip security features that surgeons have used in millions of
patients worldwide.
David McNally, President and CEO of Titan Medical, said, “Our
patented, multi-articulating instruments have been developed to
facilitate the integration of advanced tools and
technologies. This collaboration with Teleflex permits the
expansion of our robotic instrument portfolio to offer
market-leading, proven technology in a variety of surgical
disciplines. Teleflex is a leading and innovative medical
technology company with whom we share a common purpose of improving
patient outcomes with clinically-inspired technology. We are proud
to be working with them.”
James Ferguson, President and General Manager of the Surgical
Division of Teleflex, said, “We continue to partner with leading
robotic companies to allow surgeons globally to use our trusted
Weck ligation solutions. We are excited about Titan Medical
integrating our technology into its single-port robotic surgery
system.”
About Titan Medical Inc.
Titan Medical Inc. is focused on computer-assisted robotic
surgical technologies for application in MIS. The Company is
developing the SPORT Surgical System, a single-port robotic
surgical system comprised of a surgeon-controlled patient cart that
includes a 3D high-definition vision system and multi-articulating
instruments for performing MIS procedures, and a surgeon
workstation that provides an advanced ergonomic interface to the
patient cart and a 3D endoscopic view inside the patient’s body.
Titan intends initially to pursue focused surgical indications for
the SPORT Surgical System, which may include one or more of
gynecologic, urologic, colorectal or general abdominal
procedures.
For more information, please visit the Company’s website at
www.titanmedicalinc.com.
Forward-Looking Statements of Titan Medical Inc.
This news release contains “forward-looking statements” which
reflect the current expectations of management of the Company’s
future growth, results of operations, performance and business
prospects and opportunities. Wherever possible, words such as
“may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”,
“expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 31, 2018 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results, performance or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose-driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular access, interventional cardiology and radiology,
anesthesia, emergency medicine, surgical, urology and respiratory
care. Teleflex employees worldwide are united in the understanding
that what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a
common sense of purpose.
Forward-Looking Statements of Teleflex Incorporated
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on Teleflex management's current beliefs and expectations,
but are subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in Teleflex’s filings with the Securities
and Exchange Commission, including our Annual Report on Form
10-K.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190325005025/en/
For Titan Medical Inc.:LHA Investor
RelationsKim Sutton Golodetz(212) 838-3777kgolodetz@lhai.comorBruce
Voss(310) 691-7100bvoss@lhai.comFor Teleflex
Incorporated:Jake ElguiczeTreasurer and Vice President,
Investor Relations(610) 948-2836
Titan Medical (NASDAQ:TMDI)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Titan Medical (NASDAQ:TMDI)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024